2 recruiting, 1 not yet recruiting, 1 unknown. 1 Phase 1, 1 Phase 2, 1 Phase 3, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Not yet recruiting 1 |
| Phase 2 | 1 | Recruiting 1 |
| Phase 3 | 1 | Recruiting 1 |
| Phase 4 | 1 | Unknown 1 |
Follow Dupilumab Injection: new trials by email Literature Review of Dupilumab Injection trials Research Report on Dupilumab Injection
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Equivalence of IBI3027 and Dupilumab Injection in Participants With Moderate to Severe Atopic Dermatitis Dupilumab Injection, IBI3027 - Atopic Dermatitis | Phase 3 | Recruiting | Innovent Biologics (Suzhou) Co. Ltd. | 520 | 2026-09-15 | 2026-10-15 |
| Dupilumab in Major Depressive Disorder Dupilumab Injection - Major Depressive Disorder | Phase 2 | Recruiting | Icahn School of Medicine at Mount Sinai | 34 | 2026-08-27 | 2026-11-02 |
| A Study to Evaluate the Biosimilarity of GLR1044 Injection and Dupilumab Injection (Dupixent®) in Healthy Adult Male Subjects GLR1044 injection, Dupilumab Injection - Biosimilarity | Phase 1 | Not yet recruiting | Gan & Lee Pharmaceuticals. | 198 | 2026-03-09 | 2026-01-12 |
| Scientific Substantiation and Assessment of the Effectiveness of Pathogenetic Methods of Therapy for Congenital Ichthyosis in Children Secukinumab Injection, Ustekinumab Injection, Dupilumab Injection - Congenital Ichthyosis | Phase 4 | Unknown | National Medical Research Center for Children's Health, Russian Federation | 50 | 2021-03-01 | 2021-08-09 |
Depressive Disorder, Major (1) · Dermatitis, Atopic (1) · Ichthyosis Vulgaris (1) · Inflammation (1) · Netherton Syndrome (1)
Gan & Lee Pharmaceuticals. (1) · Icahn School of Medicine at Mount Sinai (1) · Innovent Biologics (Suzhou) Co. Ltd. (1) · National Medical Research Center for Children's Health, Russian Federation (1)
China (2) · Russia (1) · United States (1)